Literature DB >> 23682853

S-1 induced a durable response in metastatic extramammary Paget's disease.

Yasutomo Mikoshiba, Hisashi Uhara, Hitomi Kubo, Ryuhei Okuyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23682853     DOI: 10.1111/1346-8138.12177

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  6 in total

1.  Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease.

Authors:  Yasutaka Tokuda; Fuyuko Arakura; Hisashi Uhara
Journal:  Int J Clin Oncol       Date:  2014-04-02       Impact factor: 3.402

2.  Metastatic extramammary Paget's disease responding to weekly paclitaxel.

Authors:  Vania Phuoc; Axel Grothey
Journal:  BMJ Case Rep       Date:  2015-04-22

Review 3.  Current Management and Treatment of Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Takamichi Ito
Journal:  Curr Treat Options Oncol       Date:  2022-04-04

4.  Pemetrexed induced a durable response in heavily pretreated metastatic extramammary Paget's disease.

Authors:  Chao Wu; Hai-Tao Tao; Fang-Fang Li; Shang-Wu Huang; Wei-Wei Dong; Jin-Liang Wang; Yi Hu; Fang Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 5.  Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

Authors:  Keitaro Fukuda; Takeru Funakoshi
Journal:  Front Oncol       Date:  2018-02-16       Impact factor: 6.244

6.  Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).

Authors:  Maki Ishii; Ikuko Hirai; Keiji Tanese; Takayuki Fusumae; Yoshio Nakamura; Keitaro Fukuda; Hiroshi Uchi; Kenji Kabashima; Atsushi Otsuka; Kenji Yokota; Naoya Yamazaki; Kenjiro Namikawa; Taku Fujimura; Tatsuya Takenouchi; Yuki Yamamoto; Mana Nishiguchi; Yasunori Sato; Masayuki Amagai; Takeru Funakoshi
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.